Vagistat-1 (tioconazole) ointment is now approved for OTC use
April 1997
Vagistat-1 (tioconazole) ointment is now approved for OTC use. It's the first SINGLE-dose OTC treatment for vaginal yeast infections.
Vagistat-1 is comparable to using Terazol 3 (terconazole) or Monistat 7 (miconazole).
Tioconazole levels persist for 3 to 5 days after one dose.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 300+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote